Tag: <span>Centerview Partners</span>

North America Legal Chronicle. May 25, 2023

Ironwood Pharmaceuticals’ $1 Billion Acquisition of VectivBio Holding

By Marco Zingaro

Advestra and Latham & Watkins advise Ironwood. Homburger AG serves as legal and tax advisor to VectivBio on the transaction. Goodwin advises Centerview Partners. VectivBio Holding...

This content is for Standard 1 Year members only.
Login Join Now

North America Legal Chronicle. May 3, 2023

Astellas’ Acquisition of Iveric Bio

By Sonia Carcano

J.P. Morgan Securities LLC, acting through its affiliate JPMorgan Securities Japan Co., Ltd., acted as exclusive financial advisor to Astellas and Jones Day as Astellas’ legal...

This content is for Standard 1 Year members only.
Login Join Now

North America Legal Chronicle. April 19, 2023

Merck’s Acquisition of Prometheus Biosciences

By Laura Testa

Paul, Weiss, Rifkind, Wharton & Garrison represented Merck, Latham & Watkins represented Prometheus, Skadden represented the financial advisors on the deal. Prometheus Biosciences, Inc. have entered...

This content is for Standard 1 Year members only.
Login Join Now

North America Legal Chronicle. January 12, 2023

AstraZeneca’s Acquisition of CinCor Pharma

By Laura Testa

Covington & Burling advised AstraZeneca. Skadden represented Centerview Partners LLC, the exclusive financial advisor to CinCor Pharma Inc. Cooley advised CinCor Pharma. CinCor Pharma Inc. (“CinCor”)...

This content is for Standard 1 Year members only.
Login Join Now

Europe Legal Chronicle. December 14, 2022

Aggreko Limited’s £121.8 Million Recommended Cash Offer for CrestChic plc

By Giulia Di Palma

Ashurst advised Centerview Partners UK LLP on the deal. Travers Smith advised Crestchic plc. The transaction concerned the £121.8 million recommended cash offer for CrestChic plc...

This content is for Standard 1 Year members only.
Login Join Now

North America Legal Chronicle. November 23, 2022

Merck’s $1.35 Billion Acquisition of Imago BioSciences, Inc.

By Martina Bellini

Goodwin Procter advised Centerview Partners on the deal, Latham & Watkins represented Imago BioSciences, Gibson Dunn & Crutcher advised Merck. Merck (NYSE: MRK) and Imago BioSciences, Inc....

This content is for Standard 1 Year members only.
Login Join Now

North America Legal Chronicle. November 23, 2022

PTC’s $1.46 Billion Acquisition of ServiceMax

By Martina Bellini

Goodwin Procter advised PTC on the deal, Ropes & Gray represented ServiceMax, Latham & Watkins represented Centerview Partners. PTC (NASDAQ: PTC) signed its definitive agreement to acquire...

This content is for Standard 1 Year members only.
Login Join Now

North America Legal Chronicle. November 3, 2022

Blucora’s US$720 Million Sale of TaxAct

By Martina Bellini

Sidley and Haynes and Boone advised Blucora, Inc. on the deal. Latham & Watkins represented Centerview Partners LLC and PJT Partners. Ropes & Gray advised Cinven....

This content is for Standard 1 Year members only.
Login Join Now

North America Legal Chronicle. September 3, 2022

Shift’s Acquisition of CarLotz

By Naoual Sadouqi

Freshfields advised CarLotz on the deal. Davis Polk advised the financial advisers. CarLotz, Inc. (Nasdaq: LOTZ), a leading consignment-to-retail used vehicle marketplace, was sold to Shift...

This content is for Standard 1 Year members only.
Login Join Now

North America Legal Chronicle. August 11, 2022

Pfizer’s Acquisition of Global Blood Therapeutics

By Laura Testa

Wachtell, Lipton, Rosen & Katz represented Pfizer, while Cravath, Swaine & Moore and Goodwin Procter represented Global Blood Therapeutics in the transaction. Latham & Watkins represented the...

This content is for Standard 1 Year members only.
Login Join Now

North America Legal Chronicle. May 12, 2022

Pfizer’s Acquisition of Biohaven Pharmaceutical

By Laura Testa

Ropes & Gray, working alongside Walkers, represented Pfizer, while Skadden advised Centerview Partners, the financial advisor to Biohaven Pharmaceutical on the deal. S&C, Maples and Calder...

This content is for Standard 1 Year members only.
Login Join Now

PredictionStrike’s $10 Million Series A Financing Round

Linear’s $35 Million Series B Financing Round

Igneo Infrastructure Partners’ Acquisition of Majority Equity Interest in Soltage

Eco135 Concessionaria de Rodovias’ Project Finance

Province of Tierra del Fuego’s US$7 Million Debt Issuance

Metalcred XI’s US$6 Million Debt Issuance

Stendörren’s Green Bond Offering

Gresham House Ventures’ Backing of Branchspace

Stirling Square Capital Partners’ Acquisition of a Majority Stake in Infobric

Post For Investment’s Acquisition of Roaderz Technologies

YANMU Logistics Park’s Financing Agreement with CIB

Beltone’s Share Purchase Agreement with Cash

Panaxia Labs Israel’s Share Swap Agreement with the Barak Group

Menora Mivtachim’s Public Offering

International Schools Partnership’s Acquisition of The English College

Asia Healthcare Holdings’ Acquisition of Majority Stake in Asian Institute of Nephrology and Urology

Bayfront Infrastructure’s US$410 Million Asset-Backed Securities

Pioneer Reward Limited’s US$3 Billion Medium Term Note Programme

stevensdrake Welcomes Nusrat Qureishi as Head of Corporate and Commercial Law, Associate Director

Polsinelli Continues Corporate Growth Momentum With Two New Shareholders in St. Louis

King & Spalding Obtains Foreign Law License from the Saudi Arabia’s Ministry of Justice

Cultural Heritage Sites With Restrictions On Intended Use: The Council of State Acknowledges That This Power Lies In the Hands Of The Ministry Of Culture

The Italian Revenue Agency Qualifies Directors’ Reversible Remuneration For The Purposes Of Double Taxation Agrements.

Presumption of “Tax Inversion”: The Italian Supreme Court Clarifues That “Mediated” Control Is Not Relevant

stevensdrake Welcomes Nusrat Qureishi as Head of Corporate and Commercial Law, Associate Director

Polsinelli Continues Corporate Growth Momentum With Two New Shareholders in St. Louis

Leading Corporate and M&A Partner Joins Squire Patton Boggs in Dubai

Centerview Partners

Ironwood Pharmaceuticals’ $1 Billion Acquisition of VectivBio Holding

Astellas’ Acquisition of Iveric Bio

Merck’s Acquisition of Prometheus Biosciences

Pfizer’s Acquisition of Seagen

AstraZeneca’s Acquisition of CinCor Pharma

Aggreko Limited’s £121.8 Million Recommended Cash Offer for CrestChic plc

Merck’s $1.35 Billion Acquisition of Imago BioSciences, Inc.

PTC’s $1.46 Billion Acquisition of ServiceMax

Blucora’s US$720 Million Sale of TaxAct

Shift’s Acquisition of CarLotz

Pfizer’s Acquisition of Global Blood Therapeutics

Pfizer’s Acquisition of Biohaven Pharmaceutical